These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12893220)

  • 1. A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values.
    Mikami M; Suzuki A; Takehara K; Komiyama S; Ishikawa M; Hirose T
    Gynecol Oncol; 2003 Aug; 90(2):462-5. PubMed ID: 12893220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary splenic metastasis of an adenocarcinoma of the ovaries.
    Max LD; Stastny JF; Frable WJ
    Gynecol Obstet Invest; 1996; 42(3):214-6. PubMed ID: 8938479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary splenic metastasis of ovarian cancer.
    Furukawa N
    Arch Gynecol Obstet; 2007 Jun; 275(6):499-502. PubMed ID: 17096159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer.
    Otrock ZK; Seoud MA; Khalifeh MJ; Makarem JA; Shamseddine AI
    Int J Gynecol Cancer; 2006; 16(5):1933-5. PubMed ID: 17009994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
    Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
    J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer.
    Fayed ST; Ahmad SM; Kassim SK; Khalifa A
    Dis Markers; 1998 Nov; 14(3):155-60. PubMed ID: 10427474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Human Epididymis Protein 4 (HE4) Have a Role in Prediction of Recurrent Epithelial Ovarian Cancer.
    Innao P; Pothisuwan M; Pengsa P
    Asian Pac J Cancer Prev; 2016; 17(9):4483-4486. PubMed ID: 27797265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
    Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
    Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries.
    Mariampillai AI; Cruz JPD; Suh J; Sivapiragasam A; Nevins K; Hindenburg AA
    Anticancer Res; 2017 Jul; 37(7):3649-3656. PubMed ID: 28668856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of combined PET/CT for patient with epithelial ovarian cancer showing recurrence based on tumor marker CA125.
    Muramatsu T; Yamashita E; Takahashi K; Sugiyama T; Tsukada H; Kondo A; Hirasawa T; Murakami M; Yasuda S; Mikami M
    Tokai J Exp Clin Med; 2007 Mar; 32(1):23-7. PubMed ID: 21319052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of determining tumor markers CEA, CA125 and CA72-4 in blood serum of patients with ovarian carcinoma].
    Kokocińska D; Worwag J; Tomala J; Dzieciuchowicz L; Nowak S; Kuśmierski S
    Ginekol Pol; 1994 Sep; 65(9):495-501. PubMed ID: 7721162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of solitary splenic metastasis from an ovarian cancer 12 years after primary resection].
    Hasegawa H; Naitoh H; Tsuchihashi H; Okada K; Furukawa H; Hanasawa K
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1799-803. PubMed ID: 20841951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cathepsin L levels in serum in some patients with ovarian cancer: comparison with CA125 and CA72-4.
    Nishida Y; Kohno K; Kawamata T; Morimitsu K; Kuwano M; Miyakawa I
    Gynecol Oncol; 1995 Mar; 56(3):357-61. PubMed ID: 7705668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Brenner tumors of the ovary and tumor markers: case reports.
    Yamamoto R; Fujita M; Kuwabara M; Sogame M; Ebina Y; Sakuragi N; Kato H; Fujimoto S
    Jpn J Clin Oncol; 1999 Jun; 29(6):308-13. PubMed ID: 10418561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
    Zhang M; Cheng S; Jin Y; Zhao Y; Wang Y
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188503. PubMed ID: 33421585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer.
    Bian J; Li B; Kou XJ; Liu TZ; Ming L
    Asian Pac J Cancer Prev; 2013; 14(11):6241-3. PubMed ID: 24377511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
    Kobayashi H; Sumimoto K; Terao T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
    Xin B; Ji KQ; Liu YS; Zhao XD
    Reprod Sci; 2021 Mar; 28(3):745-756. PubMed ID: 33125687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.